Skip to content
Saturday, October 10, 2026
Gold Industries Blog

Social Media Content Creators Driving Unofficial Trade for Unlicensed Weight-Loss Medication

An underground economy for unapproved weight-loss medications is propelled by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Experimental Drug Acquiring Popularity Online

Retatrutide, which remains in research studies, is being promoted by online personalities for its alleged fat-burning effects. Followers are urged to contact these accounts privately for supplier links, while also obtaining promotional offers.

Active Commerce on Social Networks

Separately, a flourishing trade exists on messaging services, where communities with thousands of members share “before and after” images, injection guides and assertions of rapid British shipping. Sellers market the substance there before directing customers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.

Medical Experts Voice Worries

Nevertheless, physicians and chemists have warned that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could result in individuals administering products of uncertain source.

Several professionals stated the demand for the experimental drug could be linked to the rising cost of approved weight loss treatments such as Mounjaro.

Legal Status and Implementation

Selling retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still breach pharmaceutical, advertising, and customer regulations, potentially leading to fines, prosecution or prison.

Platform Response and Content Elimination

According to TikTok, the platform has taken down violative material and prohibited associated keywords and search suggestions. The company stated it was committed to keeping the service safe and investing in enhancing enforcement strategies.

Digital Marketplace Operations

Investigations also found groups with up to nine thousand participants selling retatrutide using the platform's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” immediately brings up channels with numerous of members, populated with photos of slimming results, glowing reviews and detailed instructions for mixing or administering at residence.

Within moments of joining one group, a seller posted WhatsApp details, where the majority of transactions occur. The vendor sent an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one asked about weight, health issues or past usage.

Product Details and Pricing

Inside these communities, posts display black plastic parcels with Royal Mail stickers, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at home with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20mg. When asked how long a injector should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for the messaging service stated it actively monitored dangerous material on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting substances they can’t verify. Even if the research behind this drug is sound, these online products may not contain what they claim,” stated Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in interest to recent price rises for authorized weight-loss drugs such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But counterfeit treatments are highly risky. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she explained.

Her team has already encountered patients injured by personal administration from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or communication platforms is taking chances with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Statement

A representative from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a company investigational product not yet authorized … may subject patients to potentially significant medical dangers”.

By

Eric Nelson

A financial analyst specializing in commodity markets with over a decade of experience in precious metals trading and portfolio management.

Gold Industries Blog

Type to search articles.